Transient Responses to NOTCH and TLX1/HOX11 Inhibition in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
2011

Inhibition of TLX1 and NOTCH in T-Cell Acute Lymphoblastic Leukemia

Sample size: 7 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lesley A. Rakowski, Erica A. Lehotzky, Mark Y. Chiang

Primary Institution: University of Michigan

Hypothesis

Can TLX1 and NOTCH inhibition improve treatment strategies for T-cell acute lymphoblastic leukemia?

Conclusion

Inhibiting TLX1 and NOTCH can delay leukemia progression, but the effects are transient.

Supporting Evidence

  • TLX1 inhibition reduced leukemia growth by 28%.
  • NOTCH inhibition extended median survival by 17 days.
  • TLX1 and NOTCH inhibition together increased apoptosis in leukemia cells.

Takeaway

This study shows that blocking certain genes can help slow down a type of blood cancer in mice, but it doesn't completely stop it.

Methodology

The study used a conditional doxycycline-regulated mouse model to test the effects of TLX1 and NOTCH inhibition on leukemia progression.

Limitations

The effects of inhibiting TLX1 and NOTCH were only temporary, and tumors eventually escaped inhibition.

Statistical Information

P-Value

0.0439

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016761

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication